Package 42291-973-60

Brand: valganciclovir

Generic: valganciclovir hydrochloride
NDC Package

Package Facts

Identity

Package NDC 42291-973-60
Digits Only 4229197360
Product NDC 42291-973
Product ID 42291-973_48c2e236-ce58-2ce4-e063-6294a90af3ae
Description

60 TABLET, FILM COATED in 1 BOTTLE (42291-973-60)

Marketing

Marketing Status
Marketed Since 2023-12-21
Brand valganciclovir
Generic valganciclovir hydrochloride
Sample Package No

Linked Drug Pages (1)

Valganciclovir ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "48c2e236-ce58-2ce4-e063-6294a90af3ae", "openfda": {"unii": ["4P3T9QF9NZ"], "rxcui": ["313566"], "spl_set_id": ["0d0bbc91-27f6-29bc-e063-6394a90a0027"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (42291-973-60)", "package_ndc": "42291-973-60", "marketing_start_date": "20231221"}], "brand_name": "Valganciclovir", "product_id": "42291-973_48c2e236-ce58-2ce4-e063-6294a90af3ae", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "DNA Polymerase Inhibitors [MoA]", "Nucleoside Analog Antiviral [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "42291-973", "generic_name": "Valganciclovir hydrochloride", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valganciclovir", "active_ingredients": [{"name": "VALGANCICLOVIR HYDROCHLORIDE", "strength": "450 mg/1"}], "application_number": "ANDA200790", "marketing_category": "ANDA", "marketing_start_date": "20231221", "listing_expiration_date": "20271231"}